Enaleni (soon to be renamed Cipla Medpro South Africa Ltd) is South Africa’s sixth largest and fastest growing pharmaceutical company through its subsidiary Cipla Medpro, which has access to one of the best pipelines in the world through a 20 year supply agreement with Cipla India, and commands a substantial share of the local chronic [...]
Archive for the ‘Enaleni’ Category
Enaleni Pharmaceuticals – R3.84 target price?
Posted in Enaleni, tagged analyst, Enaleni, liquid share, medicine market, pharmaceutical, prospect, undervalued, upside, view on October 10, 2008 | 3 Comments »